Brief: Senti Bio Says Highlights Preclinical Data From Logic-Gated Gene Circuit CAR-NK Cell Therapy SENTI-202

Senti Biosciences Holdings

11/12/2022 14:05

Dec 11 (Reuters) - Senti Biosciences Inc  SNTI.O :
    * SENTI BIO HIGHLIGHTS PRECLINICAL DATA FROM LOGIC-GATED
GENE
CIRCUIT CAR-NK CELL THERAPY SENTI-202 AT ASH ANNUAL MEETING AND
INVESTOR EVENT
    * SENTI-202 IS ON TRACK FOR IND FILING IN 2H 2023

Source text for Eikon:  ID:nGNXqVNn6 
Further company coverage:  SNTI.O 
 ((Reuters.Briefs@thomsonreuters.com;))